American biopharmaceutical company at San Francisco in California, listed on Nasdaq, which took its present name in 2001 after growing out of Inhale Therapeutic Systems, founded in 1990. Now works on immunology, with rezpegaldesleukin, a regulatory T cell stimulating treatment in trials for atopic dermatitis and alopecia areata, and earlier built the polymer conjugation and inhaled delivery technologies behind marketed products such as pegfilgrastim and certolizumab pegol.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen